Javier Pérez‐Calvo

679 total citations
16 papers, 398 citations indexed

About

Javier Pérez‐Calvo is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Javier Pérez‐Calvo has authored 16 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Javier Pérez‐Calvo's work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Javier Pérez‐Calvo is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Javier Pérez‐Calvo collaborates with scholars based in Spain, United States and India. Javier Pérez‐Calvo's co-authors include Enrique J. Andreu, Felipe Prósper, Susana Inogés, Mercedes Rodrı́guez-Calvillo, Ascensión López-Dı́az de Cerio, Eduardo P. C. Rocha, Maurizio Bendandi, Natalia Zabalegui, Ignacio Pérez‐Roger and Carmen Ivorra and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Javier Pérez‐Calvo

15 papers receiving 394 citations

Peers

Javier Pérez‐Calvo

ONCOL

IMMUN

HEMAT

GENET

Dariusz Woszczyk Poland

Stefan Habringer Germany

Scott D. Lunin United States

Evangelia M. Dimitriadou Greece

Rafael Martínez Spain

Atsushi Shinagawa Japan

Τατιάνα Τζένου Greece

Ricardo Alvarez United States

Rapp Mj France

Irene Ricca Italy

Dariusz Woszczyk Poland

Javier Pérez‐Calvo

119 ×0.7

ONCOL

109 ×0.8

97 ×0.8

IMMUN

139 ×1.3

HEMAT

99 ×1.2

GENET

Citations per year, relative to Javier Pérez‐Calvo Javier Pérez‐Calvo (= 1×) peers Dariusz Woszczyk

Countries citing papers authored by Javier Pérez‐Calvo

Since Specialization

Citations

This map shows the geographic impact of Javier Pérez‐Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Pérez‐Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Pérez‐Calvo more than expected).

Fields of papers citing papers by Javier Pérez‐Calvo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Pérez‐Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Pérez‐Calvo. The network helps show where Javier Pérez‐Calvo may publish in the future.

Co-authorship network of co-authors of Javier Pérez‐Calvo

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Pérez‐Calvo. A scholar is included among the top collaborators of Javier Pérez‐Calvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Pérez‐Calvo. Javier Pérez‐Calvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Petrone, Patrizio, Javier Pérez‐Calvo, Collin Brathwaite, Shahidul Islam, & D’Andrea K. Joseph. (2019). Traumatic kidney injuries: A systematic review and meta-analysis. International Journal of Surgery. 74. 13–21. 24 indexed citations

Pérez‐Calvo, Javier, et al.. (2018). Tratamiento neoadyuvante con imatinib de un tumor gigantedel estroma gastrointestinal rectal. Revista Colombiana de Cirugía. 33(4). 428–432. 1 indexed citations

Prósper, Felipe, Jaime Cosín, Ángel Panizo, et al.. (2017). Utilización de Células Madre en Terapia Regenerativa Cardíaca. Revista de medicina de la Universidad de Navarra. 24–28.

D’Avola, Delia, Francisco Carmona-Torre, Míriam Méndez, et al.. (2016). Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells. Translational research. 188. 80–91.e2. 28 indexed citations

Arranz, R., Ana García‐Noblejas, Javier Pérez‐Calvo, et al.. (2013). First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group. Haematologica. 98(10). 1563–1570. 23 indexed citations

Arranz, Reyes, Ana García‐Noblejas, Carlos Grande, et al.. (2009). Feasability and Toxicity After Induction Treatment with Rituximab-HCVAD and Metotrexate/Citarabine, Followed by Consolidation with Y-90 Ibritumomab Tiuxetan (Phase II GELTAMO–LCM 04-02 study).. Blood. 114(22). 1703–1703. 1 indexed citations

Nieto, Yago, Azucena Aldaz, J. Rifón, et al.. (2007). Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors. Biology of Blood and Marrow Transplantation. 13(11). 1324–1337. 9 indexed citations

Rifón, J., et al.. (2007). [Anemia in chronic lymphatic leukemia: is erythropoietin the solution?].. PubMed. 51(1). 3–10. 1 indexed citations

Inogés, Susana, Mercedes Rodrı́guez-Calvillo, Natalia Zabalegui, et al.. (2006). Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma. JNCI Journal of the National Cancer Institute. 98(18). 1292–1301. 111 indexed citations

10.

Rubia, Javier de la, Joan Bladé, Josep‐María Ribera, et al.. (2006). Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.. PubMed. 91(5). 621–7. 40 indexed citations

11.

Andreu, Enrique J., Elisa Lledó, Enric Poch, et al.. (2005). BCR-ABL Induces the Expression of Skp2 through the PI3K Pathway to Promote p27Kip1 Degradation and Proliferation of Chronic Myelogenous Leukemia Cells. Cancer Research. 65(8). 3264–3272. 104 indexed citations

12.

Zabalegui, Natalia, Ascensión López-Dı́az de Cerio, Susana Inogés, et al.. (2004). Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies.. PubMed. 89(5). 541–6. 26 indexed citations

13.

Rodríguez, J., Emiliano Calvo, Javier Cortés, et al.. (2002). Docetaxel Plus Vinorelbine as Salvage Chemotherapy in Advanced Breast Cancer: A Phase II Study. Breast Cancer Research and Treatment. 76(1). 47–56. 17 indexed citations

14.

Pérez‐Calvo, Javier, et al.. (2001). Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study. Bone Marrow Transplantation. 28(3). 235–242. 3 indexed citations

15.

Pérez‐Calvo, Javier, et al.. (2001). Factors Determining the Actual Received Dose Intensity in a Program of Multicyclic Dose-Intensive Alternating Chemotherapy with Sequential Stem Cell Support. Acta Haematologica. 105(3). 137–142. 2 indexed citations

16.

Bertrand, Claude, et al.. (1975). Alteration of Pain Perception by Stereotactic Lesions of Fronto-Thalamic Pathways. Stereotactic and Functional Neurosurgery. 37(1-3). 113–118. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact